1 / 67

Value-Driven Healthcare: A Federal Priority

Value-Driven Healthcare: A Federal Priority. Barry M. Straube, M.D. Centers for Medicare & Medicaid Services CMS-ESRD Network Annual Conference February 28, 2007. Table 3.6 Number of Medicare Beneficiaries, 1970-2030. The number of people Medicare serves will nearly double by 2030. 76.8.

aurek
Download Presentation

Value-Driven Healthcare: A Federal Priority

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Value-Driven Healthcare:A Federal Priority Barry M. Straube, M.D. Centers for Medicare & Medicaid Services CMS-ESRD Network Annual Conference February 28, 2007

  2. Table 3.6 Number of Medicare Beneficiaries, 1970-2030 The number of people Medicare serves will nearly double by 2030. 76.8 61.0* 45.9 Medicare Enrollment (millions) 39.6* 34.3 28.4* 20.4 * Numbers may not sum due to rounding. Source: CMS, Office of the Actuary.

  3. A Variation Problem Dartmouth Atlas of Healthcare

  4. The Healthcare Value Imperative • We spend more per capita on healthcare than any other country in the world • In spite of those expenditures, US Healthcare quality is often inferior to other nations and often doesn’t meet expected evidence-based guidelines • There are significant variations in quality and costs across the nation and there appears to often be an inverse relationship between quality and expenditures (cost) • CMS is responsible for the healthcare of a growing number of persons • CMS, in partnership and collaboration with other healthcare leaders, must demonstrate leadership in addressing these issues

  5. Patient Counts & Counts of New & Returning Dialysis Patients

  6. Prevalent patient counts, by modality

  7. Medicare vs. non-Medicare ESRD spending

  8. Incident & prevalent rates of ESRD, by modality

  9. Geographic variations in incident rates by modality: hemodialysis, 2004

  10. Geographic variations in incident rates by modality: peritoneal dialysis, 2004

  11. Geographic variations in incident rates by modality: transplant, 2004

  12. Geographic variations in prevalent rates by modality: hemodialysis, 2004

  13. Geographic variations in prevalent rates by modality: PD, 2004

  14. Geographic variations in prevalent rates by modality: transplant, 2004

  15. Transplant wait list & wait times, by race

  16. Geographic variations in median transplant wait time (in years), 2004

  17. Vascular access use in dialysis patients

  18. Dialysis adequacy: Mean URR (%)

  19. Dialysis adequacy : Mean weekly Kt/V

  20. Patient distribution, by mean monthly hemoglobin (g/dl)

  21. Mean monthly hemoglobin & mean EPO dose per week

  22. Diabetic preventive care

  23. Overall compliance with prescription drug therapy

  24. Change in all-cause & cause-specific hospitalization rates since 1993

  25. Adjusted five-year survival, by first modality

  26. Costs of the ESRD, Medicare,& EGHP programs

  27. Per person per year total Medicare ESRD expenditures

  28. Per person per year Medicare ESRD expenditures, by modality

  29. Total healthcare patient costs for compliance vs. non-compliance with drug therapy

  30. Healthy People 2010 targets & levels achieved

  31. ESRD Value Imperative • Growing number of patients needing renal replacement therapy • Epidemic of CKD: 20 Million Americans • Increasing shortfall of donor kidneys • Unless we can mitigate progression of CKD, increasing need for dialytic services • Quality of care has improved for a number of clinical performance measures in ESRD • Many of these have started to level off or reach a peak

  32. ESRD Value Imperative • Many other metrics of quality have not improved in ESRD and there are many “opportunities for improvement” we’re not addressing • Particularly true for compliance with medications, infections, etc. • We will not meet Health People 2010 Goals globally • There are wide variations in treatment modality usage, outcomes, costs of ESRD care • Regional, facility variations • Health disparities • CMS, in collaboration with the renal community, needs to address these imperatives

  33. Congressional & Employer Interests • Many opportunities for improving the quality of healthcare services, outcomes and efficiency • Increasing reimbursement for healthcare services leads to: • No uniform or widespread improvement in quality • Increased utilization of some services • Net increase in overall healthcare expenditures • Congress & employers looking to CMS and healthcare providers to demonstrate ability to improve quality, avoid unnecessary complications and costs • Overall Medicare payment reform linked

  34. Healthcare Transparency Initiative • Administration’s Transparency Initiative • Making available quality and price/cost information • Allowing consumers, employers, payers to choose & effect higher value healthcare • Presidential Executive Order & Secretary’s Value-Driven Health Care Initiative • Providing quality information • Providing price/cost information • Promote interoperable HIT systems • Implement incentives to promote higher quality & greater efficiency in healthcare

  35. Value-Driven Healthcare Initiative • Community Leaders (Tier 1) • Early-stage community collaboration efforts in healthcare quality • Recognized by the Secretary of HHS • Value Exchanges (Tier 2) • Local collaboratives focused on transparency, quality improvement and use of aggregated quality, efficiency & cost/price data • Designated by the Secretary HHS • Learning Networks run by AHRQ • Chartered for Medicare data access by CMS

  36. Value-Driven Healthcare Initiative • Better Quality Information for Medicare Beneficiaries: BQI Pilots via AQA (Tier 3) • WI, MN, IN, MA, AZ, CA • Testing of data aggregation & public reporting of commercial, Medicare, & other data • Pilot site use of quality data for benefit of Medicare beneficiaries: • Quality improvement • Consumer & employer choice of providers • Pay-for-Performance and other incentives for higher quality and efficiency

  37. CMS as a Public Health Agency • Using CMS influence and financial leverage, in partnership with other healthcare stakeholders, to transform American healthcare system • Focusing on not just Medicare & Medicaid, but also Commercial, uninsured, etc. • Quality, Value, Efficiency, Cost-effectiveness • Person-centeredness • Assisting patients and providers in receiving evidence-based, technologically-advanced care while reducing avoidable complications & unnecessary costs

  38. CMS Quality Roadmap • VISION: The right care for every person every time • Make care: • Safe • Effective • Efficient • Patient-centered • Timely • Equitable

  39. CMS Quality Roadmap: Strategies • Work through partnerships to achieve specific quality goals • Publish quality measurements and information as a basis for supporting more effective quality improvement efforts • Pay in a way that expresses our commitment to quality, efficiency & value • Promote health information technology adoption • Promote evidence development for coverage and clinical purposes

  40. CMS P4P Initiatives • Hospitals • Nursing Homes • Home Health Agencies • Dialysis Facilities • Physician Offices • More to come……. • Cross-setting quality & efficiency focus (care across the continuum) increasingly important

  41. CMS P4P Initiatives (MMA & Before) • Hospital Quality Initiative (MMA section 501b) • Premier Hospital Quality Incentive Demo • Physician Group Practice Demo (BIPA 2000) • Medicare Care Management Performance Demo (MMA section 649) • Medicare Health Care Quality Demo (MMA section 646) • Chronic Care Improvement Program (MMA section 721)

  42. CMS P4P Initiatives (MMA & Before) • ESRD Disease Management Demo (MMA section 623) • Disease Management Demo for Severely Chronically Ill Medicare Benficiaries (BIPA 2000) • Disease Management Demo for Chronically Ill Dual-Eligible Beneficiaries • Care Management for High-Cost Beneficiaries

  43. Deficit Reduction Act of 2005 • Medicare Part A • Hospital Value-based purchasing plan • Demonstration projects in gainsharing • Post-acute care payment reform demonstration project • Hospital quality reporting: measure set expanded • Hospital-acquired infections: Non-payment for 2 conditions • Medicare Part A and Part B • Home Health Agency quality reporting • Prelude to wider P4P in Federal programs ?

  44. Tax Relief & Healthcare Act of 2006 • Establishes a 1.5% bonus payment for physician office submission of quality measures between July 1, 2007 and December 31, 2007 (PQRI) • Will use PVRP measures initially, but CMS must develop an expanded group of consensus-based measures via NQF or AQA or similar groups • By August 15, 2007: Publish proposed measures in FR • By November 15, 2007: Publish final list of measures • Allows for measures reported in registries • Sets stage for further Congressional action in 2008 re: physician payment structure and P4P

  45. Hospital Quality Initiative • National Voluntary Hospital Reporting Initiative (NVHRI) public-private initiative • Federation of American Hospitals • AHA • AAMC • CMS , JCAHO, others • Hospital Quality Alliance • Medicare Modernization Act of 2003: Section 501b – Financial incentive of 0.4%

More Related